Koers Pulse Biosciences, Inc.
Aandelen
PLSE
US74587B1017
Geavanceerde medische apparatuur & technologie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,38 USD | -1,20% | +1,79% | -39,62% |
01/04 | Sectorupdate: Gezondheidszorgaandelen dalen laat in de middag | MT |
01/04 | Aandelen Pulse Biosciences dalen na Q4-resultaten, plannen voor claimemissie | MT |
Omzet 2021 | 1,42 1,33 | Omzet 2022 | 0,7 0,66 | Marktkapitalisatie | 103 mln. 96,84 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -63 mln. -59,16 mln. | Nettowinst (verlies) 2022 | -58 mln. -54,47 mln. | EV/omzet 2021 | 297.232.229 x |
Nettoliquiditeiten 2021 | 17,36 mln. 16,31 mln. | Nettoschuld 2022 | 14,82 mln. 13,92 mln. | EV/omzet 2022 | 168.485.877 x |
K/w-verhouding 2021 |
-6,51
x | K/w-verhouding 2022 |
-1,61
x | Werknemers | 61 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 29,62% |
Recentste transcriptie over Pulse Biosciences, Inc.
1 dag | -1,20% | ||
1 week | +1,79% | ||
Lopende maand | -15,15% | ||
1 maand | -24,59% | ||
3 maanden | -12,96% | ||
6 maanden | +78,93% | ||
Lopend jaar | -39,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Danahy
CEO | Chief Executive Officer | 54 | 14-02-22 |
Chief Tech/Sci/R&D Officer | - | 03-05-23 | |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Duggan
CHM | Chairman | 79 | 02-11-17 |
Director/Board Member | 46 | 02-11-17 | |
Darrin R. Uecker
CTO | Chief Tech/Sci/R&D Officer | 59 | 15-09-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.36% | 4 M€ | -5,15% | - | |
0.00% | 34 M€ | +1,08% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 7,39 | -1,07% | 52 425 |
17-04-24 | 7,47 | -3,98% | 149 671 |
16-04-24 | 7,78 | -0,51% | 113 563 |
15-04-24 | 7,82 | +8,31% | 328 356 |
12-04-24 | 7,22 | -0,55% | 133 963 |
uitgestelde koers Nasdaq, 18 april 2024 om 19:37 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-39,62% | 412 mln. | |
+2,05% | 209 mld. | |
+2,14% | 177 mld. | |
+9,94% | 133 mld. | |
+16,81% | 99,89 mld. | |
-2,70% | 61,83 mld. | |
+13,00% | 52,51 mld. | |
-6,21% | 45,54 mld. | |
-4,10% | 39,43 mld. | |
+9,73% | 38,87 mld. |